Table 1.
Patients | N = 99 |
---|---|
Age (years), M (range) | 42 (22–66) |
BMI (kg/m2), M (range) | 23.5 (15.6–32.5) |
BMI (kg/m2), (N, %) | |
< 18.5 | 5 (5.0%) |
18.5–24.9 | 61 (61.6%) |
25–29.9 | 28 (28.4%) |
30–34.9 | 5 (5.0%) |
Diabetes mellitus (N, %) | 1 (1.0%) |
Coagulation disorder (N, %) | 5 (5.1%) |
Active smoker (N, %) | 22 (22.2%) |
Preoperative chemotherapy (N, %) | 51 (51.5%) |
Preoperative radiation (N, %) | 53 (53.5%) |
Indication for breast reconstruction (N, %) | |
Therapeutic mastectomy due to breast cancer | 82 (82.8%) |
Idiopathic | 49 (49.5%) |
BRCA1 or BRCA2 gene mutation | 33 (33.3%) |
Prophylactic mastectomy (BRCA1 or BRCA2) | 14 (14.2%) |
Poland syndrome (N, %) | 1 (1.0%) |
Breast aplasia (N, %) | 1 (1.0%) |
Mastopathy (N, %) | 1 (1.0%) |
Reconstruction laterality (N, %) | |
Unilateral | 39 (39.4%) |
Bilateral | 60 (60.6%) |
N number, M mean, BMI body mass index